Your browser doesn't support javascript.
loading
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit.
Jiménez-Ruiz, Carlos A; Andreas, Stefan; Lewis, Keir E; Tonnesen, Philip; van Schayck, C P; Hajek, Peter; Tonstad, Serena; Dautzenberg, Bertrand; Fletcher, Monica; Masefield, Sarah; Powell, Pippa; Hering, Thomas; Nardini, Stefano; Tonia, Thomy; Gratziou, Christina.
Afiliação
  • Jiménez-Ruiz CA; Smoking Cessation Service, Community of Madrid, Madrid, Spain victorina@ctv.es.
  • Andreas S; Lungenfachklinik Immenhausen and Pneumology, Universitätsmedizin Göttingen, Göttingen, Germany.
  • Lewis KE; Dept of Respiratory Medicine, Prince Philip Hospital and Swansea College of Medicine, Swansea, UK.
  • Tonnesen P; Dept of Sleep Medicine, Glostrup Hospital, Glostrup, Denmark.
  • van Schayck CP; Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, The Netherlands.
  • Hajek P; Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Tonstad S; Section for Preventive Cardiology, Oslo University Hospital, Oslo, Norway.
  • Dautzenberg B; Pulmonology, Groupe Hospitalier Pitie-Salpetriere, France.
  • Fletcher M; Education for Health, Warwick, UK.
  • Masefield S; European Lung Fundation, Sheffield, UK.
  • Powell P; European Lung Fundation, Sheffield, UK.
  • Hering T; Lungenarztpraxis Tegel, Berlin, Germany.
  • Nardini S; Pulmonary and TB Unit, Ospedale Civile, Vittorio Veneto, Italy.
  • Tonia T; Institute of Social and Preventive Medicine, University of Bern, Switzerland.
  • Gratziou C; University Centre for Research and Smoking Cessation, Evgenidio Hospital, Medical School, Athens University, Athens, Greece.
Eur Respir J ; 46(1): 61-79, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25882805
ABSTRACT
Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary tuberculosis are common pulmonary diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with pulmonary diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking.This is a qualitative review regarding smoking cessation in patients with COPD and other pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tabagismo / Fumar / Abandono do Hábito de Fumar / Doença Pulmonar Obstrutiva Crônica / Pneumopatias Tipo de estudo: Clinical_trials / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tabagismo / Fumar / Abandono do Hábito de Fumar / Doença Pulmonar Obstrutiva Crônica / Pneumopatias Tipo de estudo: Clinical_trials / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article